It'll be a better buy when it drops to $1.60. That's my trigger to get back in. Traditionally, this stock's SP has increased into the end of the year/January.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025